Chengdu Kanghong Pharmaceutical Group Co., Ltd (SHE:002773)
China flag China · Delayed Price · Currency is CNY
24.49
-0.81 (-3.20%)
Apr 28, 2026, 3:04 PM CST

SHE:002773 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash & Equivalents
6,2746,4355,6904,7023,5852,939
Trading Asset Securities
440---100200
Cash & Short-Term Investments
6,7146,4355,6904,7023,6853,139
Cash Growth
10.49%13.11%21.00%27.59%17.41%-5.67%
Accounts Receivable
203.84189.1177.85160.41160.69204.63
Other Receivables
8.8937.3121.6728.8127.8843.59
Receivables
212.73226.4199.52189.22188.57248.22
Inventory
412.54407.05386.86403.61330.96295.62
Prepaid Expenses
-1.64----
Other Current Assets
100.113.9312.9310.6324.2215.89
Total Current Assets
7,4397,0846,2895,3064,2293,699
Property, Plant & Equipment
2,2182,2532,3532,4112,5532,097
Long-Term Investments
15.5815.7916.4416.7816.9817.73
Other Intangible Assets
343.22352.93286.89316.8331.14278.21
Long-Term Deferred Tax Assets
97.78128.85259.46358.08486.31545.66
Long-Term Deferred Charges
79.6461.76123.2499.3370.4784.67
Other Long-Term Assets
15.823.0714.4822.0133.93233.89
Total Assets
10,2109,9209,3428,5307,7216,956
Accounts Payable
179.33221.43297.16344.03409.54343.13
Accrued Expenses
25.73189.45233.88203.64169.59174.63
Current Portion of Leases
1.291.681.730.531.62.57
Current Income Taxes Payable
78.7618.0413.319.8219.6916.49
Current Unearned Revenue
16.532.068.925.19.148.39
Other Current Liabilities
284.29169.0599.9891.3184.1122.16
Total Current Liabilities
585.93601.72654.99654.43693.66667.37
Long-Term Leases
0.911.823.471.483.274.43
Long-Term Unearned Revenue
29.6832.123.5822.9430.325.51
Long-Term Deferred Tax Liabilities
10.069.5813.037.945.142.06
Other Long-Term Liabilities
4.82--30.9681.48151.71
Total Liabilities
631.4645.22695.07717.76813.85851.08
Common Stock
921.32921.32919.78919.46919.46919.46
Additional Paid-In Capital
2,0312,0311,9971,9901,9941,986
Retained Earnings
6,6566,3485,7384,8963,9893,185
Comprehensive Income & Other
-1.18-1.45-1.33-1.34-1.05-0.83
Total Common Equity
9,6079,2998,6537,8046,9026,090
Minority Interest
-28.55-24.27-6.347.895.0715.24
Shareholders' Equity
9,5789,2758,6477,8126,9076,105
Total Liabilities & Equity
10,2109,9209,3428,5307,7216,956
Total Debt
2.23.515.22.014.877
Net Cash (Debt)
6,7126,4325,6844,7003,6813,132
Net Cash Growth
10.52%13.15%20.94%27.70%17.52%-5.88%
Net Cash Per Share
7.276.976.205.134.023.42
Filing Date Shares Outstanding
921.32921.32919.78919.46919.46919.46
Total Common Shares Outstanding
921.32921.32919.78919.46919.46919.46
Working Capital
6,8536,4835,6344,6513,5353,031
Book Value Per Share
10.4310.099.418.497.516.62
Tangible Book Value
9,2638,9468,3667,4876,5715,812
Tangible Book Value Per Share
10.059.719.108.147.156.32
Buildings
-2,1112,1261,9891,7851,137
Machinery
-1,3871,2711,2361,088830.91
Construction In Progress
-97.56112.35166.54475.88808.69
Source: S&P Global Market Intelligence. Standard template. Financial Sources.